Principal Financial Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,288
Closed -$84.6K 2406
2024
Q2
$84.6K Sell
10,288
-8,317
-45% -$68.4K ﹤0.01% 2235
2024
Q1
$143K Buy
18,605
+243
+1% +$1.87K ﹤0.01% 2228
2023
Q4
$165K Buy
18,362
+157
+0.9% +$1.41K ﹤0.01% 2196
2023
Q3
$163K Sell
18,205
-177
-1% -$1.58K ﹤0.01% 2198
2023
Q2
$282K Buy
18,382
+2,452
+15% +$37.7K ﹤0.01% 2093
2023
Q1
$358K Sell
15,930
-903
-5% -$20.3K ﹤0.01% 2048
2022
Q4
$354K Sell
16,833
-15,914
-49% -$335K ﹤0.01% 2061
2022
Q3
$807K Sell
32,747
-29,298
-47% -$722K ﹤0.01% 1872
2022
Q2
$1.5M Buy
+62,045
New +$1.5M ﹤0.01% 1851
2022
Q1
Sell
-7,267
Closed -$226K 2601
2021
Q4
$226K Sell
7,267
-4,175
-36% -$130K ﹤0.01% 2325
2021
Q3
$277K Sell
11,442
-1,856
-14% -$44.9K ﹤0.01% 2332
2021
Q2
$194K Sell
13,298
-9,815
-42% -$143K ﹤0.01% 2481
2021
Q1
$577K Buy
23,113
+210
+0.9% +$5.24K ﹤0.01% 2119
2020
Q4
$625K Buy
+22,903
New +$625K ﹤0.01% 2056
2019
Q2
Sell
-19,153
Closed -$433K 2278
2019
Q1
$433K Buy
19,153
+501
+3% +$11.3K ﹤0.01% 1969
2018
Q4
$422K Sell
18,652
-8,507
-31% -$192K ﹤0.01% 1953
2018
Q3
$780K Buy
27,159
+8,144
+43% +$234K ﹤0.01% 1888
2018
Q2
$518K Sell
19,015
-2,213
-10% -$60.3K ﹤0.01% 1959
2018
Q1
$475K Buy
21,228
+1,950
+10% +$43.6K ﹤0.01% 1947
2017
Q4
$406K Sell
19,278
-2,056
-10% -$43.3K ﹤0.01% 2005
2017
Q3
$531K Hold
21,334
﹤0.01% 1920
2017
Q2
$414K Buy
21,334
+8,596
+67% +$167K ﹤0.01% 1986
2017
Q1
$235K Hold
12,738
﹤0.01% 2064
2016
Q4
$241K Buy
+12,738
New +$241K ﹤0.01% 2062
2015
Q3
Sell
-6,027
Closed -$200K 2221
2015
Q2
$200K Buy
+6,027
New +$200K ﹤0.01% 2047